IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 321 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,711,151 | +10.3% | 81,816 | -0.3% | 0.00% | +50.0% |
| Q2 2023 | $3,365,876 | +36.5% | 82,035 | +18.9% | 0.00% | 0.0% |
| Q1 2023 | $2,465,846 | -11.9% | 68,994 | -6.9% | 0.00% | 0.0% |
| Q4 2022 | $2,798,719 | -15.3% | 74,099 | -0.9% | 0.00% | -33.3% |
| Q3 2022 | $3,306,000 | +8.8% | 74,740 | -9.0% | 0.00% | 0.0% |
| Q2 2022 | $3,039,000 | -13.2% | 82,087 | -13.2% | 0.00% | 0.0% |
| Q1 2022 | $3,502,000 | +29.8% | 94,553 | +6.6% | 0.00% | +50.0% |
| Q4 2021 | $2,698,000 | -3.8% | 88,666 | +6.0% | 0.00% | -33.3% |
| Q3 2021 | $2,804,000 | +18.5% | 83,615 | +41.0% | 0.00% | +50.0% |
| Q2 2021 | $2,366,000 | -4.8% | 59,316 | +7.3% | 0.00% | -33.3% |
| Q1 2021 | $2,486,000 | -17.2% | 55,283 | +4.2% | 0.00% | -25.0% |
| Q4 2020 | $3,001,000 | +26.8% | 53,079 | +6.5% | 0.00% | 0.0% |
| Q3 2020 | $2,366,000 | -13.1% | 49,857 | +7.9% | 0.00% | -20.0% |
| Q2 2020 | $2,724,000 | +23.0% | 46,193 | -1.4% | 0.01% | 0.0% |
| Q1 2020 | $2,215,000 | -20.4% | 46,848 | +1.7% | 0.01% | 0.0% |
| Q4 2019 | $2,782,000 | +0.7% | 46,052 | -0.1% | 0.01% | -16.7% |
| Q3 2019 | $2,762,000 | -6.3% | 46,095 | +0.5% | 0.01% | 0.0% |
| Q2 2019 | $2,947,000 | -18.2% | 45,854 | +3.3% | 0.01% | -25.0% |
| Q1 2019 | $3,602,000 | +47.3% | 44,376 | -1.9% | 0.01% | +14.3% |
| Q4 2018 | $2,445,000 | +6.5% | 45,227 | +1.6% | 0.01% | +16.7% |
| Q3 2018 | $2,296,000 | +20.1% | 44,513 | -2.9% | 0.01% | +20.0% |
| Q2 2018 | $1,911,000 | -6.0% | 45,856 | -0.5% | 0.01% | -16.7% |
| Q1 2018 | $2,032,000 | -20.3% | 46,100 | -9.0% | 0.01% | -25.0% |
| Q4 2017 | $2,549,000 | +13.7% | 50,677 | +14.6% | 0.01% | 0.0% |
| Q3 2017 | $2,242,000 | +517.6% | 44,212 | +520.2% | 0.01% | +700.0% |
| Q2 2017 | $363,000 | +21.4% | 7,129 | -8.1% | 0.00% | -50.0% |
| Q1 2017 | $299,000 | -23.5% | 7,758 | -6.0% | 0.00% | -33.3% |
| Q4 2016 | $391,000 | +16.0% | 8,256 | -12.6% | 0.00% | 0.0% |
| Q3 2016 | $337,000 | -61.7% | 9,449 | -54.4% | 0.00% | +50.0% |
| Q1 2016 | $880,000 | -45.9% | 20,699 | -22.4% | 0.00% | -60.0% |
| Q4 2015 | $1,627,000 | – | 26,690 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |